Chronic obstructive pulmonary disease.

Chronic obstructive pulmonary disease (COPD) is a common problem in the elderly. The disease is characterised by intermittent worsening of symptoms and these episodes are called acute exacerbations. The best estimate, based on several lines of evidence, is that approximately half of all exacerbations are caused by bacteria. These lines of evidence include studies of lower respiratory tract bacteriology during exacerbations, correlation of airways’ inflammation with results of sputum cultures during exacerbations, analysis of immune responses to bacterial pathogens, and the observation in randomised, prospective, placebo-controlled trials that antibacterial therapy is of benefit. The most important bacterial causes of exacerbations of COPD are nontypeable Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae and Chlamydia pneumoniae.

[1]  A. Sandford,et al.  Genetic risk factors of chronic obstructive pulmonary disease. , 1997, Swiss medical weekly.

[2]  J. Hogg,et al.  Chronic obstructive pulmonary disease: an overview of pathology and pathogenesis. , 2008, Novartis Foundation symposium.

[3]  J. Zalewska-kaszubska,et al.  Anti-inflammatory capabilities of macrolides. , 2001, Pharmacological research.

[4]  J. Bartlett,et al.  A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. , 2001, Archives of internal medicine.

[5]  I. Boldur,et al.  Chlamydia pneumoniae Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Analysis of 250 Hospitalizations , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[6]  A. Hoberman,et al.  Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media , 2001, The Pediatric infectious disease journal.

[7]  D. O’Donnell,et al.  Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[8]  M. Leinonen,et al.  Infectious etiologies in acute exacerbation of COPD. , 2001, Diagnostic microbiology and infectious disease.

[9]  Marilyn Roberts,et al.  Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance , 2001, Microbiology and Molecular Biology Reviews.

[10]  G. Doern,et al.  Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  V. Snow,et al.  Evidence Base for Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2001, Annals of Internal Medicine.

[12]  D. Mccrory,et al.  Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence , 2001, Annals of Internal Medicine.

[13]  T. Murphy,et al.  Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review , 2001, Clinical Microbiology Reviews.

[14]  S. Sethi,et al.  Acute Exacerbations of Chronic Bronchitis , 2001, Drugs & aging.

[15]  R. Grossman,et al.  The Chronic Obstructive Pulmonary Disease Exacerbation , 2000, Clinics in Chest Medicine.

[16]  R. Bonomo Multiple antibiotic-resistant bacteria in long-term-care facilities: An emerging problem in the practice of infectious diseases. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  B. Grant,et al.  Airway inflammation and etiology of acute exacerbations of chronic bronchitis. , 2000, Chest.

[18]  R. Stockley,et al.  Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. , 2000, The American journal of medicine.

[19]  D. Hansell,et al.  Effect of lung-volume-reduction surgery in patients with severe emphysema. , 2000, The New England journal of medicine.

[20]  M. Niederman,et al.  The role of bacteria in exacerbations of COPD. A constructive view. , 2000, Chest.

[21]  J. Hirschmann Do bacteria cause exacerbations of COPD? , 2000, Chest.

[22]  R. Stockley,et al.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.

[23]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[24]  A. Anzueto,et al.  Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. , 2000, Chest.

[25]  N. Pride,et al.  Tumour necrosis factor-α gene promoter polymorphism in chronic obstructive pulmonary disease , 2000 .

[26]  K. Chung,et al.  No effect of inhaled budesonide on the response to inhaled ozone in normal subjects. , 2000, American journal of respiratory and critical care medicine.

[27]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[28]  P. Barnes,et al.  Mechanisms in COPD: differences from asthma. , 2000, Chest.

[29]  T. Seemungal,et al.  Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.

[30]  N. Payne,et al.  Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial , 2000, The Lancet.

[31]  Dirkje S Postma,et al.  Ongoing airway inflammation in patients with COPD who do not currently smoke , 1999, Chest.

[32]  Joan Wilson,et al.  Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[33]  G. Criner,et al.  Prospective Randomized Trial Comparing Bilateral Lung Volume Reduction Surgery to Pulmonary Rehabilitation in Severe Chronic Obstructive Pulmonary Disease , 1999 .

[34]  D. Postma,et al.  Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. , 1999, American journal of respiratory and critical care medicine.

[35]  S. Sethi Etiology and Management of Infections in Chronic Obstructive Pulmonary Disease , 1999 .

[36]  A. Chaouat,et al.  A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. , 1999, The European respiratory journal.

[37]  R. Stockley Neutrophils and protease/antiprotease imbalance. , 1999, American journal of respiratory and critical care medicine.

[38]  A. Torres,et al.  Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[39]  W. Maziak,et al.  Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[40]  P. Barnes,et al.  Novel approaches and targets for treatment of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[41]  A. Agustí,et al.  Serial measurements of exhaled nitric oxide during exacerbations of chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[42]  N. Keicho,et al.  Endotoxin-specific NF-κB activation in pulmonary epithelial cells harboring adenovirus E1A. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[43]  R. Stockley,et al.  The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. , 1999, American journal of respiratory and critical care medicine.

[44]  T. Murphy,et al.  Analysis of Antigenic Structure and Human Immune Response to Outer Membrane Protein CD of Moraxella catarrhalis , 1999, Infection and Immunity.

[45]  L. Davies,et al.  Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial , 1999, The Lancet.

[46]  D. Hornick,et al.  Infection of Primary Human Bronchial Epithelial Cells by Haemophilus influenzae: Macropinocytosis as a Mechanism of Airway Epithelial Cell Entry , 1999, Infection and Immunity.

[47]  B. Isalska,et al.  Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. , 1999, American journal of respiratory and critical care medicine.

[48]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[49]  D. Niewoehner,et al.  Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. , 1999, The New England journal of medicine.

[50]  S. Shapiro,et al.  Matrix metalloproteinases. Matrix degradation and more. , 1999, American journal of respiratory cell and molecular biology.

[51]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[52]  T. Braciale,et al.  Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand. , 1999, American journal of respiratory cell and molecular biology.

[53]  J. Dankert,et al.  Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity. , 1999, Microbial pathogenesis.

[54]  C. Westermann,et al.  Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[55]  T. Seemungal,et al.  Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease. , 1999, The European respiratory journal.

[56]  S. Christensen,et al.  Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic. , 1999, Pulmonary pharmacology & therapeutics.

[57]  J. Nadel,et al.  Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. , 1999, American journal of respiratory cell and molecular biology.

[58]  S. Yancey,et al.  Efficacy of salmeterol xinafoate in the treatment of COPD. , 1999, Chest.

[59]  F. Maltais,et al.  Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. , 1999, The European respiratory journal.

[60]  Aker,et al.  A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. , 1999, The New England journal of medicine.

[61]  P. Barnes Molecular genetics of chronic obstructive pulmonary disease , 1999 .

[62]  J. C. Campbell,et al.  Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. , 1999, The Journal of antimicrobial chemotherapy.

[63]  T. Witek,et al.  Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. , 1999, Life sciences.

[64]  Steven Piantadosi,et al.  Rationale and design of the national emphysema treatment trial: A prospective randomized trial of lung volume reduction surgery , 1999 .

[65]  T. Betsuyaku,et al.  Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. , 1999, American journal of respiratory and critical care medicine.

[66]  E. Wouters,et al.  Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[67]  R. Richmond Teaching medical students about tobacco. , 1999, Thorax.

[68]  F. Brennan,et al.  Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. , 1998, Transplantation proceedings.

[69]  G. FitzGerald,et al.  Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. , 1998, American journal of respiratory and critical care medicine.

[70]  D. O’Donnell,et al.  Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[71]  X. Busquets,et al.  Expression of adhesion molecules and G proteins in circulating neutrophils in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[72]  A. Anzueto,et al.  Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[73]  L. Fabbri,et al.  Severity of airflow limitation is associated with severity of airway inflammation in smokers. , 1998, American journal of respiratory and critical care medicine.

[74]  M J Connolly,et al.  Quality of life in elderly patients with COPD: measurement and predictive factors. , 1998, Respiratory medicine.

[75]  Y. Konttinen,et al.  Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[76]  M. Antonelli,et al.  A Comparison of Noninvasive Positive-Pressure Ventilation and Conventional Mechanical Ventilation in Patients with Acute Respiratory Failure , 1998 .

[77]  D. Felmingham REVIEW OF THE COMPARATIVE IN VITRO ACTIVITY OF SOME ORAL CEPHALOSPORINS , 1998 .

[78]  D. Nicolau PHARMACODYNAMIC CONSIDERATIONS IN ORAL CEPHALOSPORIN THERAPY-. IMPLICATIONS FOR SELECTION AND EFFECTIVENESS , 1998 .

[79]  F. Maltais,et al.  Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[80]  B. Balbi,et al.  Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease. , 1998, The European respiratory journal.

[81]  C. Sanguinetti,et al.  Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation. , 1998, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[82]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[83]  M. Niederman,et al.  Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. , 1998, Chest.

[84]  D. Lomas,et al.  Alpha1-antitrypsin deficiency, cirrhosis and emphysema , 1998 .

[85]  S. E. Jones,et al.  Domiciliary nocturnal intermittent positive pressure ventilation in patients with respiratory failure due to severe COPD: long term follow up and effect on survival , 1998, Thorax.

[86]  R. Rodríguez-Roisín,et al.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. , 1998, American journal of respiratory and critical care medicine.

[87]  T. Seemungal,et al.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[88]  R. Hertzberg,et al.  Identification of a Potent, Selective Non-peptide CXCR2 Antagonist That Inhibits Interleukin-8-induced Neutrophil Migration* , 1998, The Journal of Biological Chemistry.

[89]  David W. Kaczka,et al.  Relation between preoperative inspiratory lung resistance and the outcome of lung-volume-reduction surgery for emphysema. , 1998, The New England journal of medicine.

[90]  P. Paggiaro,et al.  Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease , 1998, The Lancet.

[91]  L. Fabbri,et al.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[92]  W. Timens,et al.  Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[93]  W. Maziak,et al.  Exhaled nitric oxide in chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[94]  P. Jeffery,et al.  Structural and inflammatory changes in COPD: a comparison with asthma. , 1998, Thorax.

[95]  T. Torphy Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. , 1998, American journal of respiratory and critical care medicine.

[96]  P. Barnes New therapies for chronic obstructive pulmonary disease. , 1998, Thorax.

[97]  E. Wouters,et al.  Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease , 1998 .

[98]  R. Doyle,et al.  Lung volume reduction surgery for the treatment of chronic obstructive pulmonary disease. , 1998, Advances in internal medicine.

[99]  M. Johnson,et al.  Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro. , 1998, The European respiratory journal.

[100]  Alan D. Lopez,et al.  The global burden of disease, 1990–2020 , 1998, Nature Medicine.

[101]  E. R. Mcfadden,et al.  Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.

[102]  C Brennen,et al.  Multiply Antibiotic Resistant Gram-Negative Bacilli in a Long Term Care Facility A Case Control Study of Patient rick Factors and Prior Antibiotic Use , 1997, Infection Control & Hospital Epidemiology.

[103]  R. Grossman Guidelines for the treatment of acute exacerbations of chronic bronchitis. , 1997, Chest.

[104]  Song-Lih Huang,et al.  Tumor Necrosis Factor- α Gene Polymorphism in Chronic Bronchitis , 1997 .

[105]  D. Albanes,et al.  The effect of alpha-tocopherol and beta-carotene supplementation on COPD symptoms. , 1997, American journal of respiratory and critical care medicine.

[106]  T. Murphy,et al.  Human immune response to nontypeable Haemophilus influenzae in chronic bronchitis. , 1997, The Journal of infectious diseases.

[107]  S. Shapiro,et al.  Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.

[108]  D. Harrison,et al.  Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema , 1997, The Lancet.

[109]  A Bast,et al.  Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. , 1997, American journal of respiratory and critical care medicine.

[110]  D. Górecka,et al.  Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. , 1997, Thorax.

[111]  T. Murphy,et al.  Antigenic characterization and analysis of the human immune response to outer membrane protein E of Branhamella catarrhalis , 1997, Infection and immunity.

[112]  L. O’Driscoll,et al.  Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. , 1997, American journal of respiratory and critical care medicine.

[113]  T. Kohyama,et al.  Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. , 1997, American journal of respiratory and critical care medicine.

[114]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[115]  A. Morice,et al.  An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) , 1997, The European respiratory journal.

[116]  M. Leinonen,et al.  Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease , 1997, Epidemiology and Infection.

[117]  P. Jeffery,et al.  Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. , 1997, American journal of respiratory and critical care medicine.

[118]  P. Barnes,et al.  Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. , 1997, American journal of respiratory and critical care medicine.

[119]  P. Borm,et al.  Blood antioxidant status in coal dust induced respiratory disorders: a longitudinal evaluation of multiple biomarkers , 1997 .

[120]  H Vannucchi,et al.  Assessment of vitamin A status in chronic obstructive pulmonary disease patients and healthy smokers. , 1996, The American journal of clinical nutrition.

[121]  G. Patterson,et al.  Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[122]  G. O'Connor,et al.  Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. , 1996, American journal of respiratory and critical care medicine.

[123]  Gordon H Guyatt,et al.  Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease , 1996, The Lancet.

[124]  M. Reed Clinical pharmacokinetics of amoxicillin and clavulanate. , 1996, The Pediatric infectious disease journal.

[125]  W. MacNee,et al.  Systemic oxidative stress in asthma, COPD, and smokers. , 1996, American journal of respiratory and critical care medicine.

[126]  K. Aben,et al.  Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[127]  E. Wouters,et al.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.

[128]  S. Rennard,et al.  Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. , 1996, Chest.

[129]  U. Kucich,et al.  MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. , 1996, The European respiratory journal.

[130]  A. Agustí,et al.  Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease. , 1996, The European respiratory journal.

[131]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[132]  J. Vestbo,et al.  Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.

[133]  D. Maldonado,et al.  Woodsmoke exposure and risk for obstructive airways disease among women. , 1996, Chest.

[134]  R. Rogers,et al.  Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. , 1996, American journal of respiratory and critical care medicine.

[135]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[136]  T. Cawston Metalloproteinase inhibitors and the prevention of connective tissue breakdown. , 1996, Pharmacology & therapeutics.

[137]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[138]  W. Knaus,et al.  Hospital and 1-Year Survival of Patients Admitted to Intensive Care Units With Acute Exacerbation of Chronic Obstructive Pulmonary Disease , 1995 .

[139]  T. Betsuyaku,et al.  Excessive neutrophil elastase in bronchoalveolar lavage fluid in subclinical emphysema. , 1995, American journal of respiratory and critical care medicine.

[140]  M. Cosio,et al.  Alveolar inflammation and its relation to emphysema in smokers. , 1995, American journal of respiratory and critical care medicine.

[141]  L. Fabbri,et al.  Effect of smoking cessation on airway inflammation in chronic bronchitis. , 1995, American journal of respiratory and critical care medicine.

[142]  J. Ruiz,et al.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. , 1995, American journal of respiratory and critical care medicine.

[143]  E. Wouters,et al.  Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. , 1995, American journal of respiratory and critical care medicine.

[144]  B. Celli,et al.  Long-term oxygen therapy. , 1995, The New England journal of medicine.

[145]  R. Davies,et al.  Effect of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells. , 1995, The European respiratory journal.

[146]  P. Jones,et al.  Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. , 1995, American journal of respiratory and critical care medicine.

[147]  B. Meyboom-de Jong,et al.  Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. , 1995, Thorax.

[148]  E. Shahar,et al.  Fish consumption may limit the damage of smoking on the lung. , 1995, American journal of respiratory and critical care medicine.

[149]  E. Vittinghoff,et al.  Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.

[150]  J. M. Harris,et al.  Acute infective exacerbations of chronic bronchitis. , 1995, QJM : monthly journal of the Association of Physicians.

[151]  L. Fabbri,et al.  Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.

[152]  R. Davies,et al.  Effect of Haemophilus influenzae endotoxin on the synthesis of IL-6, IL-8, TNF-alpha and expression of ICAM-1 in cultured human bronchial epithelial cells. , 1994, The European respiratory journal.

[153]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[154]  D. Strachan,et al.  Chest illness in infancy and chronic respiratory disease in later life: an analysis by month of birth. , 1994, International journal of epidemiology.

[155]  P. Laippala,et al.  Prevalence of chronic obstructive pulmonary disease in elderly Finns. , 1994, Respiratory medicine.

[156]  A. Askari Nutrition and Diagnosis-Related Care, 3rd edition , 1994 .

[157]  A. Lindberg,et al.  Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay , 1994, Infection and immunity.

[158]  D. Mant,et al.  Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation , 1994, The Lancet.

[159]  F. Blasi,et al.  Chlamydia pneumoniae infection in acute exacerbations of COPD. , 1993, The European respiratory journal.

[160]  T. Murphy,et al.  Bacterial infection in chronic obstructive pulmonary disease. , 1992, The American review of respiratory disease.

[161]  W. Jefferies,et al.  Latent adenoviral infection in the pathogenesis of chronic airways obstruction. , 1992, The American review of respiratory disease.

[162]  R. Millman,et al.  Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[163]  P. Allhoff,et al.  The Second National Health and Nutrition Examination Survey (NHANES II) , 1991 .

[164]  J. Fagon,et al.  Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. , 1990, The American review of respiratory disease.

[165]  George,et al.  Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. , 1990, The Journal of clinical investigation.

[166]  N. Anthonisen,et al.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. , 1987, Annals of internal medicine.

[167]  D. Musher,et al.  Development of bactericidal antibody during Branhamella catarrhalis infection. , 1985, The Journal of infectious diseases.

[168]  D. Musher,et al.  Pneumonia and acute febrile tracheobronchitis due to haemophilus influenzae. , 1983, Annals of internal medicine.

[169]  F. Speizer,et al.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.

[170]  I. Gregg,et al.  A study of infective and other factors in exacerbations of chronic bronchitis , 1980, British Journal of Diseases of the Chest.

[171]  R. Kanner,et al.  Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis , 1976, The Journal of infectious diseases.

[172]  C. A. Phillips,et al.  Role of infection in chronic bronchitis. , 1976, The American review of respiratory disease.

[173]  F. Speizer,et al.  Role of infection in chronic bronchitis. , 1975, The New England journal of medicine.

[174]  B. Burrows,et al.  Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. , 1969, The New England journal of medicine.

[175]  Fletcher Cm Chronic bronchitis. Its prevalence, nature, and pathogenesis. , 1959 .